Proteomic Identification of Plasma Biomarkers in Children and Adolescents with Recurrent Hodgkin Lymphoma

The treatment of paediatric Hodgkin lymphoma (HL) has steadily improved over the years, so that 10- years survival exceed 80%. The purpose of this study was to identify prognostic markers for relapsed HL that might contribute to optimize therapeutic approaches. To this aim we retrospectively analyse...

Descripción completa

Detalles Bibliográficos
Autores principales: Repetto, Ombretta, Mussolin, Lara, Elia, Caterina, Martina, Lia, Bianchi, Maurizio, Buffardi, Salvatore, Sala, Alessandra, Burnelli, Roberta, Mascarin, Maurizio, De Re, Valli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299395/
https://www.ncbi.nlm.nih.gov/pubmed/30588249
http://dx.doi.org/10.7150/jca.27560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299395/
https://www.ncbi.nlm.nih.gov/pubmed/30588249
http://dx.doi.org/10.7150/jca.27560

Ejemplares similares